Cargando…
Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
OBJECTIVE: To investigate salivary cortisol samples in patients with Parkinson's disease (PD) with and without impulsive compulsive behaviours (ICB) during a risk task. METHODS: Salivary cortisol levels were measured in 13 PD patients without ICB (PD−ICB) and in 15 PD patients with ICB (PD+ICB)...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171980/ https://www.ncbi.nlm.nih.gov/pubmed/21478206 http://dx.doi.org/10.1136/jnnp.2011.245746 |
_version_ | 1782211811450290176 |
---|---|
author | Djamshidian, Atbin O'Sullivan, Sean S Papadopoulos, Andrew Bassett, Paul Shaw, Karen Averbeck, Bruno B Lees, Andrew |
author_facet | Djamshidian, Atbin O'Sullivan, Sean S Papadopoulos, Andrew Bassett, Paul Shaw, Karen Averbeck, Bruno B Lees, Andrew |
author_sort | Djamshidian, Atbin |
collection | PubMed |
description | OBJECTIVE: To investigate salivary cortisol samples in patients with Parkinson's disease (PD) with and without impulsive compulsive behaviours (ICB) during a risk task. METHODS: Salivary cortisol levels were measured in 13 PD patients without ICB (PD−ICB) and in 15 PD patients with ICB (PD+ICB) before, after medication and throughout the day, and were compared with results with 14 healthy controls. All participants also performed a gambling task to assess risk taking behaviour. RESULTS: Significantly higher diurnal cortisol levels were found in the PD−ICB group compared with healthy controls but no differences were seen between the PD+ICB and the control group. Increased cortisol levels were significantly correlated with increased risk taking in PD+ICB patients but no interaction was found in the PD−ICB group. CONCLUSIONS: The findings are in keeping with previous studies which have linked low cortisol levels with antisocial behaviour. The higher cortisol levels during the risk task in the PD+ICB group are consistent with reports in pathological gamblers during gambling and addicts during drug abuse. The results support the hypothesis that cortisol plays an important role in risk taking in ICBs. |
format | Online Article Text |
id | pubmed-3171980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BMJ Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-31719802011-09-23 Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour Djamshidian, Atbin O'Sullivan, Sean S Papadopoulos, Andrew Bassett, Paul Shaw, Karen Averbeck, Bruno B Lees, Andrew J Neurol Neurosurg Psychiatry Research Paper OBJECTIVE: To investigate salivary cortisol samples in patients with Parkinson's disease (PD) with and without impulsive compulsive behaviours (ICB) during a risk task. METHODS: Salivary cortisol levels were measured in 13 PD patients without ICB (PD−ICB) and in 15 PD patients with ICB (PD+ICB) before, after medication and throughout the day, and were compared with results with 14 healthy controls. All participants also performed a gambling task to assess risk taking behaviour. RESULTS: Significantly higher diurnal cortisol levels were found in the PD−ICB group compared with healthy controls but no differences were seen between the PD+ICB and the control group. Increased cortisol levels were significantly correlated with increased risk taking in PD+ICB patients but no interaction was found in the PD−ICB group. CONCLUSIONS: The findings are in keeping with previous studies which have linked low cortisol levels with antisocial behaviour. The higher cortisol levels during the risk task in the PD+ICB group are consistent with reports in pathological gamblers during gambling and addicts during drug abuse. The results support the hypothesis that cortisol plays an important role in risk taking in ICBs. BMJ Group 2011-04-08 2011-10 /pmc/articles/PMC3171980/ /pubmed/21478206 http://dx.doi.org/10.1136/jnnp.2011.245746 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Research Paper Djamshidian, Atbin O'Sullivan, Sean S Papadopoulos, Andrew Bassett, Paul Shaw, Karen Averbeck, Bruno B Lees, Andrew Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour |
title | Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour |
title_full | Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour |
title_fullStr | Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour |
title_full_unstemmed | Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour |
title_short | Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour |
title_sort | salivary cortisol levels in parkinson's disease and its correlation to risk behaviour |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171980/ https://www.ncbi.nlm.nih.gov/pubmed/21478206 http://dx.doi.org/10.1136/jnnp.2011.245746 |
work_keys_str_mv | AT djamshidianatbin salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour AT osullivanseans salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour AT papadopoulosandrew salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour AT bassettpaul salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour AT shawkaren salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour AT averbeckbrunob salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour AT leesandrew salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour |